The Near-Term Viability and Benefits of eLabels for Patients, Clinical Sites, and Sponsors
Crossref DOI link: https://doi.org/10.1177/2168479018765463
Published Online: 2018-12-30
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smith-Gick, Jodi
Barnes, Nicola
Barone, Rocco
Bedford, Jeff
James, Jason R.
Reisner, Stacy Frankovitz
Stephenson, Michael
Text and Data Mining valid from 2018-09-01
Article History
Received: 5 December 2017
Accepted: 23 February 2018
First Online: 30 December 2018